PharmaCord Strengthens Leadership With Key Vice President Appointments

PharmaCord, a prominent provider of patient services and commercialization solutions for life sciences companies, has recently announced the appointment of Kari Glenn and Sarah Walker as Vice Presidents of Patient Services. With their extensive experience and leadership skills, Kari and Sarah are set to lead efforts in scaling and enhancing PharmaCord's service offerings, aiming to elevate the standard of excellence in patient services.

Denise Von Dohren, Senior Vice President of Patient Services at PharmaCord, highlighted the strategic nature of these appointments. She emphasized that empowering the teams with robust leadership is crucial for delivering more impactful and personalized solutions to their clients. Kari Glenn joins the team with over 15 years of industry experience, having held leadership roles in five notable biopharma companies. Her expertise in patient support program design and execution is complemented by her Lean Six Sigma Black Belt certification, which she leverages to drive continuous improvement across operations.

Kari's commitment to excellence has been demonstrated through her effective management of large teams focused on enhancing the patient experience. She holds a Bachelor of Science in Nursing and a Master of Arts in Organizational Leadership, with a background in nursing within a hospital setting for five years.

Sarah Walker brings her operational responsibility experience from working with some of PharmaCord’s largest and most complex client programs over five years. Her leadership journey includes roles at local Louisville businesses such as Carewise Health and Anthem. Sarah's deep understanding of insurance claims intricacies equips her to foresee and tackle both challenges and opportunities within the reimbursement sector of patient support services. She holds a Bachelor of Science in Health and Human Performance and is a Certified Health Education Specialist, accredited by the National Commission for Health Education.

In addition to these strategic appointments, PharmaCord has introduced eight further advancements within its operations to bolster leadership capacity throughout its expanding organization. Nitin Sahney, Founder and CEO of PharmaCord, expressed confidence that these developments will position the company for sustained success. He emphasized that these moves are aimed at delivering unparalleled value to their clients by focusing on patient care through innovative strategic perspectives.

About PharmaCord: PharmaCord serves as a bridge between drug manufacturers and patients, simplifying the therapeutic journey for patients. Leveraging its proprietary technology suite, PharmaCord Lynk™, alongside its talented team members and non-commercial pharmacy, PharmaCord Scripts™, the company strives to enhance patients' access to and adherence to vital medications. For more information on how PharmaCord contributes to improved commercial outcomes for life sciences companies, please visit pharmacord.com.

For media inquiries, please contact Paige Hobbs, Associate Director of Marketing at [email protected].